ROCKVILLE, Md., Dec. 27, 2006 (PRIME NEWSWIRE) (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has submitted its written appeal to the FDA. Cytomedix staff and its external experts are scheduled to meet with the agency on January 30, 2007 to present its appeal.
